Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 8:13 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2257–2280 of 2,544 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Parasomnia Clear all

Conditions: Recurrent Tonsillitis, Peritonsillar Abscess, Obstructive Sleep Apnea
Interventions: Auricular Acupuncture; Procedure
Lead sponsor: United States Naval Medical Center, San Diego; Federal
Eligibility: 18 Years and older
Enrollment: 134 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: San Diego, California

Conditions: Sleep Apnea, Obstructive
Interventions: Measurement of PPG waveforms, Measurement of Pulse Arrival Time (PAT); Device
Lead sponsor: Sotera Wireless, Inc.; Industry
Eligibility: 21 Years and older
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Escondido, California

Conditions: Sleep Disordered Breathing (SDB), Sleep Apnea
Interventions: SSAM, Polysomnography, EnsoSleep; Device · Diagnostic Test
Lead sponsor: Pathway Medtech, LLC.; Industry
Eligibility: 18 Years and older
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 3
States / cities: Burlingame, California • Irvine, California • La Jolla, California

Conditions: Narcolepsy
Interventions: JZP441, Matching Placebo; Drug
Lead sponsor: Jazz Pharmaceuticals; Industry
Eligibility: 18 Years to 64 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 4
States / cities: Atlanta, Georgia • Cincinnati, Ohio • Columbia, South Carolina + 1 more

Conditions: Sleep Initiation and Maintenance Disorders
Interventions: Melatonin 0.4 mg, Melatonin 4.0 mg, Placebo; Drug
Lead sponsor: Nalaka Gooneratne; Other
Eligibility: 65 Years and older
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Health Personnel, Stress, Anxiety, Insomnia, Depression
Interventions: Cereset Research; Device
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 100 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Sleep Apnea
Interventions: Not listed
Lead sponsor: Rami Khayat; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Obstructive Sleep Apnea
Interventions: Magnap; Device
Lead sponsor: Michael Harrison; Other
Eligibility: 21 Years to 70 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Restless Legs Syndrome
Interventions: Topiramate; Drug
Lead sponsor: Neurocare; Other
Eligibility: 18 Years to 70 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2005
U.S. locations: 1
States / cities: Newton, Massachusetts

Conditions: Restless Legs Syndrome
Interventions: GSK1838262 600 mg, GSK1838262 450 mg, GSK1838262 300 mg, GSK1838262 Placebo match; Drug
Lead sponsor: XenoPort, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 501 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 42
States / cities: Phoenix, Arizona • Tucson, Arizona • Little Rock, Arkansas + 37 more

Conditions: Obesity, Overweight, Obstructive Sleep Apnoea
Interventions: NNC0487-0111, Placebo (matched to NNC0487-0111); Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 17
States / cities: San Diego, California • Miami, Florida • Naples, Florida + 13 more

Conditions: Obstructive Sleep Apnea
Interventions: Continuous positive airway pressure apparatus; Device
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years to 90 Years
Enrollment: 296 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania • Pittsburgh, Pennsylvania

Conditions: Alcohol Use Disorder, Insomnia
Interventions: Web-Based Insomnia Education Program, SHUTi Intervention; Behavioral
Lead sponsor: Jessica Weafer; Other
Eligibility: 21 Years to 50 Years
Enrollment: 71 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Sleep Apnea
Interventions: Health coaching; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 131 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Sleep Apnea Syndrome, Obstructive Sleep Apnea, COPD, Overlap Syndrome, Quality of Life, Neurocognitive Function, Sleepiness, Elderly, Positive Airway Pressure
Interventions: Positive airway pressure, Conservative care (control arm); Device · Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 60 Years and older
Enrollment: 668 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Myotonic Dystrophy 1, Excessive Daytime Sleepiness
Interventions: Pitolisant Oral Tablet, Placebo oral tablet; Drug
Lead sponsor: Harmony Biosciences Management, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 11
States / cities: Irvine, California • Aurora, Colorado • Tampa, Florida + 8 more

Conditions: Pain, Fatigue, Sleep Disturbance, Cancer
Interventions: Cognitive-Behavioral Intervention, Attention Control; Behavioral · Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 188 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 4
States / cities: Rockford, Illinois • Janesville, Wisconsin • Madison, Wisconsin + 1 more

Conditions: Sleep Disturbance, Insomnia
Interventions: Transcranial Electrical Neuromodulation (TES); Device
Lead sponsor: Brain Electrophysiology Laboratory Company; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Eugene, Oregon

Conditions: Sleep Apnea, Insomnia, Sleep Deprivation, Sleep Disorders, Circadian Rhythm, Sleepiness, Excessive Daytime, Fatigue
Interventions: Not listed
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 25 Years to 65 Years
Enrollment: 3,680 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Insomnia, Mild Cognitive Impairment
Interventions: Cognitive BehavioralTherapy for Insomnia (CBT-I), SleepSMART; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 60 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: San Diego, California

Conditions: Insomnia, Insomnia Chronic
Interventions: Zolpidem tartrate; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 40 Years to 85 Years
Enrollment: 197 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Obstructive Sleep Apnea
Interventions: Conservative Medical Therapy (CMT), Sham PAP (Sham), Active PAP with RT Support (Active-Beh), Active PAP with Behavioral Modification (Active+Beh); Behavioral · Device
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 45 Years to 75 Years
Enrollment: 169 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Obstructive Sleep Apnea
Interventions: JZP-110; Drug
Lead sponsor: Jazz Pharmaceuticals; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 174 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 22
States / cities: Birmingham, Alabama • Oceanside, California • Orange, California + 18 more

Conditions: REM Sleep Behavior Disorder
Interventions: ramelteon, placebo; Drug
Lead sponsor: Sleep Medicine Centers of WNY; Other
Eligibility: 18 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: West Seneca, New York

Search by objective public record fields.

Auricular Acupuncture for The Treatment of Post-Tonsillectomy Pain

Assessment of PPG & PAT to Detect Upper Airway Obstruction in Patients With Obstructive Sleep Apnea

Detection of Sleep Stages and Arousals Using Neural Network Classifiers

A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1

Effects of Melatonin on Insomnia Symptoms in Older Adults

Cereset Research for Performance Improvement in a Hospital Nursing Unit

The Role of Oxidative Stress in the Cardiovascular Consequences of Sleep Apnea

Magnetic Apnea Prevention(MAGNAP) Device to Treat Obstructive Sleep Apnea:First-In-Human Study of Feasibility and Safety

Efficacy and Safety Study of Topiramate to Treat Restless Legs Syndrome

Gabapentin Enacarbil (GSK1838262) Adult Restless Leg Syndrome (RLS) Post Marketing Commitment Study

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Cost Effectiveness of Ambulatory Management for Veterans With Sleep Apnea

Testing an Online Insomnia Intervention

Health Coaching for Positive Airway Pressure Adherence

Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)

Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1

A Brief Patient-Controlled Intervention for a Symptom Cluster in Advanced Cancer

Closed Loop TES for Enhancing Slow Wave Sleep

Adult Sleep Health in the Rural Appalachia and Mississippi Delta Region and Its Relationships With Cardiometabolic Health Disparities.

SleepSMART for Veterans With Insomnia and Mild Cognitive Impairment

Partial Reinforcement II: Three Approaches to Maintenance Therapy for Chronic Insomnia

Sleep Apnea Intervention for Cardiovascular Disease Reduction

"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"

Study to Determine Whether Ramelteon Helps People With REM Sleep Behavior Disorder